{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:14:51Z","timestamp":1793697291450,"version":"4.5.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C12292 \/ A20861"],"award-info":[{"award-number":["C12292 \/ A20861"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PPRPGM-Nov20\\\\100002"],"award-info":[{"award-number":["PPRPGM-Nov20\\\\100002"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["633784"],"award-info":[{"award-number":["633784"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ypmed.2022.107075","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T03:52:33Z","timestamp":1651809153000},"page":"107075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Towards implementation of comprehensive breast cancer risk prediction tools in health care for personalised prevention"],"prefix":"10.1016","volume":"159","author":[{"given":"Sowmiya","family":"Moorthie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Babb de Villiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kroese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis C.","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Proteeti","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Garcia-Closas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjanka K.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ypmed.2022.107075_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11080726","article-title":"Risk-stratified approach to breast cancer screening in Canada: Women\u2019s knowledge of the legislative context and concerns about discrimination from genetic and other predictive health data","volume":"11","author":"Alarie","year":"2021","journal-title":"J. Pers. Med."},{"issue":"8","key":"10.1016\/j.ypmed.2022.107075_bb0010","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions","volume":"98","author":"Antoniou","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ypmed.2022.107075_bb0015","doi-asserted-by":"crossref","first-page":"e0229999","DOI":"10.1371\/journal.pone.0229999","article-title":"Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: a multi-methods study","volume":"15","author":"Archer","year":"2020","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.ypmed.2022.107075_bb0020","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1903986","article-title":"Supplemental MRI screening for women with extremely dense breast tissue","volume":"381","author":"Bakker","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0025","doi-asserted-by":"crossref","first-page":"11044","DOI":"10.1038\/s41598-020-66907-9","article-title":"Predicting breast cancer risk using interacting genetic and demographic factors and machine learning","volume":"10","author":"Behravan","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ypmed.2022.107075_bb0030","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMms2029562","article-title":"Race and genetic ancestry in medicine - a time for reckoning with racism","volume":"384","author":"Borrell","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ypmed.2022.107075_bb0035","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.ypmed.2022.107075_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11060511","article-title":"Personalized risk assessment for prevention and early detection of breast cancer: integration and implementation (PERSPECTIVE I&I)","volume":"11","author":"Brooks","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ypmed.2022.107075_bb0045","article-title":"My healthy future - technologies and social impacts","author":"Burton","year":"2019","journal-title":"PHG Foundation"},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13058-017-0852-3","article-title":"An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation","volume":"19","author":"Candido Dos Reis","year":"2017","journal-title":"Breast Cancer Res."},{"issue":"3","key":"10.1016\/j.ypmed.2022.107075_bb0055","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1158\/1055-9965.EPI-20-1319","article-title":"CanRisk tool-a web Interface for the prediction of breast and ovarian Cancer risk and the likelihood of carrying genetic pathogenic variants","volume":"30","author":"Carver","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"2","key":"10.1016\/j.ypmed.2022.107075_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-017-4247-z","article-title":"Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications","volume":"164","author":"Cintolo-Gonzalez","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13058-019-1126-z","article-title":"Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model","volume":"21","author":"Clendenen","year":"2019","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.ypmed.2022.107075_bb0070","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41416-021-01550-3","article-title":"The current status of risk-stratified breast screening","volume":"126","author":"Clift","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13058-017-0820-y","article-title":"A clinical model for identifying the short-term risk of breast cancer","volume":"19","author":"Eriksson","year":"2017","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ypmed.2022.107075_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41523-017-0035-5","article-title":"The WISDOM study: breaking the deadlock in the breast cancer screening debate","volume":"3","author":"Esserman","year":"2017","journal-title":"NPJ Breast Cancer"},{"issue":"5","key":"10.1016\/j.ypmed.2022.107075_bb0085","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s12160-017-9895-z","article-title":"Can communicating personalised disease risk promote healthy behaviour change? A systematic review of systematic reviews","volume":"51","author":"French","year":"2017","journal-title":"Ann. Behav. Med."},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0090","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1186\/s12885-020-07054-2","article-title":"What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)","volume":"20","author":"French","year":"2020","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ypmed.2022.107075_bb0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1470-2045(19)30071-3","article-title":"Assessment of breast cancer risk: which tools to use?","volume":"20","author":"Garcia-Closas","year":"2019","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.ypmed.2022.107075_bb0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12687-018-0358-4","article-title":"Risk stratification, genomic data and the law","volume":"9","author":"Hall","year":"2018","journal-title":"J. Commun. Genet."},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ypmed.2022.107075_bb0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2019.11.005","article-title":"Risk-based breast cancer screening strategies in women","volume":"65","author":"Harkness","year":"2020","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0115","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1186\/s12885-019-6279-8","article-title":"Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trials","volume":"19","author":"Harvie","year":"2019","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ypmed.2022.107075_bb0135","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/ije\/dyab036","article-title":"Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries","volume":"50","author":"Hurson","year":"2021","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.ypmed.2022.107075_bb0140","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/jbi\/wbab001","article-title":"Assessing risk of breast Cancer: a review of risk prediction models","volume":"3","author":"Kim","year":"2021","journal-title":"J. Breast Imaging"},{"issue":"8","key":"10.1016\/j.ypmed.2022.107075_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11080736","article-title":"Of screening, stratification, and scores","volume":"11","author":"Knoppers","year":"2021","journal-title":"J. Pers. Med."},{"issue":"9","key":"10.1016\/j.ypmed.2022.107075_bb0150","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jmedgenet-2019-106072","article-title":"Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1\/2 breast cancer families","volume":"56","author":"Lakeman","year":"2019","journal-title":"J. Med. Genet."},{"issue":"2","key":"10.1016\/j.ypmed.2022.107075_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263788","article-title":"Views of health professionals on risk-based breast cancer screening and its implementation in the Spanish National Health System: a qualitative discussion group study","volume":"17","author":"Laza-Vasquez","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ypmed.2022.107075_bb0160","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","article-title":"BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors","volume":"21","author":"Lee","year":"2019","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41416-019-0476-8","article-title":"A systematic review and quality assessment of individualised breast cancer risk prediction models","volume":"121","author":"Louro","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ypmed.2022.107075_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11020095","article-title":"Women\u2019s views on multifactorial breast cancer risk assessment and risk-stratified screening: a population-based survey from four provinces in Canada","volume":"11","author":"Mbuya Bienge","year":"2021","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0175","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1186\/s12885-020-07158-9","article-title":"Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders\u2019 views on a low-risk breast screening pathway","volume":"20","author":"McWilliams","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12889-021-10210-3","article-title":"Incorporating a brief intervention for personalised cancer risk assessment to promote behaviour change into primary care: a multi-methods pilot study","volume":"21","author":"Mills","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ypmed.2022.107075_bb0185","article-title":"Personalised prevention in breast cancer: the policy landscape","author":"Moorthie","year":"2017","journal-title":"PHG Foundation"},{"key":"10.1016\/j.ypmed.2022.107075_bb0190","article-title":"Personalising prevention for breast cancer: workshop report","author":"Moorthie","year":"2019","journal-title":"PHG Foundation."},{"key":"10.1016\/j.ypmed.2022.107075_bb0195","article-title":"Personalising breast cancer prevention - bridging the gap between research and policy","author":"Moorthie","year":"2020","journal-title":"PHG Foundation"},{"key":"10.1016\/j.ypmed.2022.107075_bb0200","article-title":"Polygenic scores and clinical utility","author":"Moorthie","year":"2021","journal-title":"PHG Foundation"},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12913-019-3988-2","article-title":"Communicating prognosis to women with early breast cancer - overview of prediction tools and the development and pilot testing of a decision aid","volume":"19","author":"Muhlbauer","year":"2019","journal-title":"BMC Health Serv. Res."},{"issue":"11","key":"10.1016\/j.ypmed.2022.107075_bb0210","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41591-021-01549-6","article-title":"Polygenic risk score task force of the international common disease a. responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps","volume":"27","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ypmed.2022.107075_bb0215","first-page":"49","article-title":"Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer","volume":"CG164","author":"National Insitute for Health and Care Excellence","year":"2013","journal-title":"Clin. Guide. CG164. NICE Guide."},{"issue":"3","key":"10.1016\/j.ypmed.2022.107075_bb0220","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/jnci\/djz113","article-title":"Comparative validation of breast Cancer risk prediction models and projections for future risk stratification","volume":"112","author":"Pal Choudhury","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13058-021-01399-7","article-title":"Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry","volume":"23","author":"Pal Choudhury","year":"2021","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.ypmed.2022.107075_bb0230","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/jgc4.1442","article-title":"Utilization of breast cancer risk prediction models by cancer genetic counselors in clinical practice predominantly in the United States","volume":"30","author":"Park","year":"2021","journal-title":"J. Genet. Couns."},{"issue":"11","key":"10.1016\/j.ypmed.2022.107075_bb0235","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41571-020-0388-9","article-title":"Personalized early detection and prevention of breast cancer: ENVISION consensus statement","volume":"17","author":"Pashayan","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ypmed.2022.107075_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11090916","article-title":"Should age-dependent absolute risk thresholds be used for risk stratification in risk-stratified breast Cancer screening?","volume":"11","author":"Pashayan","year":"2021","journal-title":"J. Pers. Med."},{"issue":"12","key":"10.1016\/j.ypmed.2022.107075_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044597","article-title":"Feasibility and acceptability of personalised breast cancer screening (DECIDO study): protocol of a single-arm proof-of-concept trial","volume":"10","author":"Pons-Rodriguez","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.ypmed.2022.107075_bb0250","author":"Public Health England"},{"key":"10.1016\/j.ypmed.2022.107075_bb0255","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40985-019-0111-5","article-title":"Health professionals\u2019 perspectives on breast cancer risk stratification: understanding evaluation of risk versus screening for disease","volume":"40","author":"Puzhko","year":"2019","journal-title":"Public Health Rev."},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0260","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12885-020-06745-0","article-title":"European women\u2019s perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative study","volume":"20","author":"Rainey","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ypmed.2022.107075_bb0265","series-title":"2017\/745 of the European Parliament and of the Council of 5 April 2017 on Medical Devices","author":"Regulation (EU)","year":"2022"},{"key":"10.1016\/j.ypmed.2022.107075_bb0270","series-title":"2017\/746 of the European Parliament and of the Council of 5 April 2017 on In Vitro Diagnostic Medical Devices","author":"Regulation (EU)","year":"2022"},{"issue":"3","key":"10.1016\/j.ypmed.2022.107075_bb0275","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/EDE.0000000000001173","article-title":"Aim for Clinical Utility, Not Just Predictive Accuracy","volume":"31","author":"Sachs","year":"2020","journal-title":"Epidemiology"},{"issue":"2","key":"10.1016\/j.ypmed.2022.107075_bb0280","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11673-013-9429-8","article-title":"Personalised medicine: a critique on the future of health care","volume":"10","author":"Savard","year":"2013","journal-title":"J. Bioeth. Inq."},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0285","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology."},{"key":"10.1016\/j.ypmed.2022.107075_bb0290","author":"US National Library of Medicine"},{"issue":"12","key":"10.1016\/j.ypmed.2022.107075_bb0295","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/bjc.2015.409","article-title":"Risk prediction tools for cancer in primary care","volume":"113","author":"Usher-Smith","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ypmed.2022.107075_bb0300","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017717","article-title":"Effect of interventions incorporating personalised cancer risk information on intentions and behaviour: a systematic review and meta-analysis of randomised controlled trials","volume":"8","author":"Usher-Smith","year":"2018","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.ypmed.2022.107075_bb0305","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJMms2004740","article-title":"Hidden in plain sight - reconsidering the use of race correction in clinical algorithms","volume":"383","author":"Vyas","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ypmed.2022.107075_bb0310","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1158\/1055-9965.EPI-20-0861","article-title":"Translating Cancer risk prediction models into personalized Cancer risk assessment tools: stumbling blocks and strategies for success","volume":"29","author":"Waters","year":"2020","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.ypmed.2022.107075_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195447","article-title":"Innovative technologies and social inequalities in health: a scoping review of the literature","volume":"13","author":"Weiss","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ypmed.2022.107075_bb0320","article-title":"Density and tailored breast cancer screening: practice and prediction - an overview","volume":"7","author":"Wengert","year":"2018","journal-title":"Acta Radiol. Open"},{"issue":"578","key":"10.1016\/j.ypmed.2022.107075_bb0325","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4373","article-title":"Toward robust mammography-based models for breast cancer risk","volume":"13","author":"Yala","year":"2021","journal-title":"Sci. Transl. Med."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743522001232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743522001232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:32:33Z","timestamp":1778664753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743522001232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":62,"alternative-id":["S0091743522001232"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2022.107075","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards implementation of comprehensive breast cancer risk prediction tools in health care for personalised prevention","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2022.107075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107075"}}